Here are the biggest challenges for pharma companies

Pricing pressure plagues even the largest industry players.

Multinational firms are always on the lookout for new and effective ways to rise up to the challenges emerging from China’s pharmaceutical industry. One of these major challenges include pricing pressure, which plagues big-time pharma manufacturers.

To address these challenges, Marcus Evans gathers established marketers from the globe and China to launch the 4th Annual Pharma 2016: Sales & Marketing Excellence Forum scheduled on the 24th – 25th November 2016 in Shanghai, China.

Other topics which will be covered this year include business growth in the large yet volatile market, effective expansion to broad markets, and actionable data and commercial excellence through multichannel sales and marketing tactics.

The speakers for the event include Frank Wang (Vice President of Commercial Operation, Takeda), Joseph Jia (Vice President/Business Unit Head, Shanghai CP Guojian Pharmaceutical), Victoire Maugis de Lajudie (Director, Customer Innovation, Sanofi), William Liang (Vice President, Oncology Business Unit, AstraZeneca), Timothy White (Global Head of Customer Experience, Teva Pharmaceuticals, Netherlands), Derrick Miu (Regional Integration Lead, Amgen, Hong Kong), Meilin Li (Centre of Excellence (COE) Director, Abbott) and Wei Ren (Vice President, Yabao Pharmaceuticals).

Meanwhile, the forum also focuses on the impact of regulatory changes and how pharma organisations reengineer their business growth strategy, highlighting though roundtable discussions on themes of transforming and empowering the marketing department and sales force in the age of Internet of Things (IoT).

The event is also sponsored by IMS Health, Aktana, and Veeva Systems.